SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-071302
Filing Date
2023-06-14
Accepted
2023-06-14 18:14:19
Documents
2
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2318760-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2318760-2_3seq1.xml 3 1629
2 EXHIBIT 24 tm2318760d2_ex24.htm EX-24 7629
  Complete submission text file 0001104659-23-071302.txt   10720
Mailing Address C/O POINT BIOPHARMA GLOBAL INC. 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address
Martell Bridget A (Reporting) CIK: 0001629627 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39373 | Film No.: 231015388

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Issuer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations